| 2001-04 |
東京都千代田区神田神保町に設立。 |
| 2001-04 |
Established in Kanda Jimbocho, Chiyoda-ku, Tokyo. |
| 2001-04 |
東京都千代田区神田神保町に設立。 |
| 2001-04 |
Established in Kanda Jimbocho, Chiyoda-ku, Tokyo. |
| 2002-10 |
東京都千代田区内神田へ移転。 |
| 2002-10 |
Moved to Kanda in Chiyoda-ku, Tokyo. |
| 2002-10 |
東京都千代田区内神田へ移転。 |
| 2002-10 |
Moved to Kanda in Chiyoda-ku, Tokyo. |
| 2003-01 |
眼科領域におけるガイドライン編集制作のサポート開始。 |
| 2003-01 |
Started supporting the editing and production of guidelines in the ophthalmology field. |
| 2003 |
Supported "Viral Conjunctivitis Guidelines (2003)" |
| 2003-01 |
眼科領域におけるガイドライン編集制作のサポート開始。 |
| 2003-01 |
Started supporting the editing and production of guidelines in the ophthalmology field. Supported 'Viral Conjunctivitis Guidelines (2003)', 'Contact Lens Practice Guidelines (2005)', 'Allergic Conjunctivitis Guidelines (2006)', and 'Infectious Keratitis Practice Guidelines (2007)'. |
| 2004-04 |
第10回日経BP広告賞において「日経メディカル賞」受賞。受賞作品は、武田薬品工業株式会社の国際戦略製品「ブロプレス(高血圧症治療薬)」 |
| 2004-04 |
東京都中央区日本橋兜町へ移転。 |
| 2004-04 |
Received the "Nikkei Medical Award" at the 10th Nikkei BP Advertising Awards. The award-winning work was Takeda Pharmaceutical Company Limited's international strategic product "Blopress" (hypertension treatment drug) |
| 2004-04 |
Moved to Nihonbashi Kabutocho, Chuo-ku, Tokyo. |
| 2004-04 |
第10回日経BP広告賞において「日経メディカル賞」受賞。受賞作品は、武田薬品工業株式会社の国際戦略製品「ブロプレス(高血圧症治療薬)」 |
| 2004-04 |
東京都中央区日本橋兜町へ移転。 |
| 2004-04 |
Received the 'Nikkei Medical Award' at the 10th Nikkei BP Advertising Awards. The award-winning work was Takeda Pharmaceutical Company Limited's international strategic product 'Blopress' (hypertension treatment drug). |
| 2004-04 |
Moved to Nihonbashi Kabutocho, Chuo-ku, Tokyo. |
| 2005 |
Supported "Contact Lens Practice Guidelines (2005)" |
| 2005-04 |
第11回日経BP広告賞において「日経メディカル賞」2年連続受賞。受賞作品は、武田薬品工業株式会社の国際戦略製品「ブロプレス(高血圧症治療薬)」 |
| 2005-04 |
Received the "Nikkei Medical Award" for the second consecutive year at the 11th Nikkei BP Advertising Awards. The award-winning work was Takeda Pharmaceutical Company Limited's international strategic product "Blopress" (hypertension treatment drug) |
| 2005-04 |
第11回日経BP広告賞において「日経メディカル賞」2年連続受賞。受賞作品は、武田薬品工業株式会社の国際戦略製品「ブロプレス(高血圧症治療薬)」 |
| 2005-04 |
Received the 'Nikkei Medical Award' for the second consecutive year at the 11th Nikkei BP Advertising Awards. The award-winning work was Takeda Pharmaceutical Company Limited's international strategic product 'Blopress' (hypertension treatment drug). |
| 2005-12 |
帝国データバンクによる「ライジングカンパニー2006」※に選出される。 |
| 2005-12 |
Selected as "Rising Company 2006" * by Teikoku Databank. |
| 2005-12 |
帝国データバンクによる「ライジングカンパニー2006」※に選出される。 |
| 2005-12 |
Selected as 'Rising Company 2006' * by Teikoku Databank. * Emerging growing company selected by Teikoku Databank from companies whose most recent annual sales have increased by 100 million yen or more and sales have increased by 10% or more for the second consecutive term within 10 years of establishment, and whose corporate income has been announced within the second term. This represents about 1% of the 170,000 target companies. |
| 2006 |
Supported "Allergic Conjunctivitis Guidelines (2006)" |
| 2006-04 |
弊社作成のウェブサイト「心不全.com」が日本経済新聞「夕&eye」、NIKKEI NET「いきいき健康」で紹介される。 |
| 2006-04 |
Our website "Heart Failure.com" was introduced in the Nihon Keizai Shimbun "Yu & eye" and NIKKEI NET "Ikiiki Kenko". |
| 2006-04 |
弊社作成のウェブサイト「心不全.com」が日本経済新聞「夕&eye」、NIKKEI NET「いきいき健康」で紹介される。 |
| 2006-04 |
Our website 'Heart Failure.com' was introduced in the Nihon Keizai Shimbun 'Yu & eye' and NIKKEI NET 'Ikiiki Kenko'. |
| 2006-05 |
第13回日経BP広告賞において「日経BP賞最優秀広告賞」受賞。受賞作品は、武田薬品工業株式会社の国際戦略製品「ブロプレス(高血圧症治療薬)」 |
| 2006-05 |
Received "Nikkei BP Award Best Advertising Award" at the 13th Nikkei BP Advertising Awards. The award-winning work was Takeda Pharmaceutical Company Limited's international strategic product "Blopress" (hypertension treatment drug) |
| 2006-05 |
第13回日経BP広告賞において「日経BP賞最優秀広告賞」受賞。受賞作品は、武田薬品工業株式会社の国際戦略製品「ブロプレス(高血圧症治療薬)」 |
| 2006-05 |
Received 'Nikkei BP Award Best Advertising Award' at the 13th Nikkei BP Advertising Awards. The award-winning work was Takeda Pharmaceutical Company Limited's international strategic product 'Blopress' (hypertension treatment drug). |
| 2007 |
Supported "Infectious Keratitis Practice Guidelines (2007)" |
| 2007-06 |
海外マーケティング会社「Jam Japan Marketing」と業務提携。 |
| 2007-06 |
Business tie-up with overseas marketing company "Jam Japan Marketing". |
| 2007-06 |
海外マーケティング会社「Jam Japan Marketing」と業務提携。 |
| 2007-06 |
Business tie-up with overseas marketing company 'Jam Japan Marketing'. |
| 2007-09 |
弊社主催セミナー「米国における製薬企業のマーケティング戦略と成功事例及び最新マーケティングトレンド」開催。 |
| 2007-09 |
Held our seminar "Marketing Strategies and Success Stories of Pharmaceutical Companies in the United States and Latest Marketing Trends". |
| 2007-09 |
弊社主催セミナー「米国における製薬企業のマーケティング戦略と成功事例及び最新マーケティングトレンド」開催。 |
| 2007-09 |
Held our seminar 'Marketing Strategies and Success Stories of Pharmaceutical Companies in the United States and Latest Marketing Trends'. |
| 2008-04 |
弊社代表取締役社長の近藤勝己が「第5期PBA医薬マーケティング・アカデミー」にて講演。テーマは「革新的医薬品プロモーションへの道」 |
| 2008-04 |
Katsumi Kondo, our President and CEO, gave a lecture at the 5th PBA Pharmaceutical Marketing Academy. The theme was "The Road to Innovative Drug Promotion". |
| 2008-04 |
弊社代表取締役社長の近藤勝己が「第5期PBA医薬マーケティング・アカデミー」にて講演。テーマは「革新的医薬品プロモーションへの道」。 |
| 2008-04 |
Katsumi Kondo, our President and CEO, gave a lecture at the 5th PBA Pharmaceutical Marketing Academy. The theme was 'The Road to Innovative Drug Promotion'. |
| 2008-05 |
日本眼科アレルギー研究会事務局の運営開始。 |
| 2008-05 |
Started operating as the Secretariat of the Japan Ophthalmology Allergy Study Group. |
| 2008-05 |
日本眼科アレルギー研究会事務局の運営開始。 |
| 2008-05 |
Started operating as the Secretariat of the Japan Ophthalmology Allergy Study Group. |
| 2009-12 |
東京都中央区八重洲へ移転。 |
| 2009-12 |
Moved to Yaesu, Chuo-ku, Tokyo. |
| 2009-12 |
東京都中央区八重洲へ移転。 |
| 2009-12 |
Moved to Yaesu, Chuo-ku, Tokyo. |
| 2016-12 |
エムスリーグループに参画。 |
| 2016-12 |
東京都中央区日本橋本町へ移転。 |
| 2016-12 |
Joined the M3 Group. |
| 2016-12 |
Moved to Nihonbashihoncho, Chuo-ku, Tokyo. |
| 2016-12 |
エムスリーグループに参画。 |
| 2016-12 |
東京都中央区日本橋本町へ移転。 |
| 2016-12 |
Joined the M3 Group. |
| 2016-12 |
Moved to Nihonbashihoncho, Chuo-ku, Tokyo. |
| 2022-07 |
新代表取締役社長に金谷 進、会長に近藤 勝己が就任。 |
| 2022-07 |
新代表取締役社長に金谷 進、会長に近藤 勝己が就任。 |
